133 related articles for article (PubMed ID: 11560173)
1. The effects of radiotherapy treatment uncertainties on the delivered dose distribution and tumour control probability.
Booth JT; Zavgorodni SF
Australas Phys Eng Sci Med; 2001 Jun; 24(2):71-8. PubMed ID: 11560173
[TBL] [Abstract][Full Text] [Related]
2. An evaluation method of clinical impact with setup, range, and radiosensitivity uncertainties in fractionated carbon-ion therapy.
Sakama M; Kanematsu N
Phys Med Biol; 2018 Jun; 63(13):135003. PubMed ID: 29863484
[TBL] [Abstract][Full Text] [Related]
3. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
4. Application of the equivalent uniform stochastic dose (EUSD) to TCP calculations incorporating dose uncertainty and fractionation effects.
Zavgorodni S
Australas Phys Eng Sci Med; 2008 Mar; 31(1):1-9. PubMed ID: 18488958
[TBL] [Abstract][Full Text] [Related]
5. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
6. Development of generalized time-dependent TCP model and the investigation of the effect of repopulation and weekend breaks in fractionated external beam therapy.
Lee TK; Rosen II
J Theor Biol; 2021 Mar; 512():110565. PubMed ID: 33346019
[TBL] [Abstract][Full Text] [Related]
7. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
Selvaraj J; Uzan J; Baker C; Nahum A
Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of geometric uncertainties in treatment plan evaluation.
van Herk M; Remeijer P; Lebesque JV
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1407-22. PubMed ID: 11955756
[TBL] [Abstract][Full Text] [Related]
9. EUD-based radiotherapy treatment plan evaluation: incorporating physical and Monte Carlo statistical dose uncertainties.
Cranmer-Sargison G; Zavgorodni S
Phys Med Biol; 2005 Sep; 50(17):4097-109. PubMed ID: 16177533
[TBL] [Abstract][Full Text] [Related]
10. Patient-specific voxel-level dose prescription for prostate cancer radiotherapy considering tumor cell density and grade distribution.
Zhao Y; Haworth A; Reynolds HM; Her EJ; Sun Y; Finnegan R; Rowshanfarzad P; Ebert MA
Med Phys; 2023 Jun; 50(6):3746-3761. PubMed ID: 36734620
[TBL] [Abstract][Full Text] [Related]
11. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
12. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
13. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
14. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
15. A theoretical investigation of adequate range uncertainty margins in proton treatment planning to preserve tumor control probability.
Taasti VT; Jeong J; Jackson A; Deasy JO
Acta Oncol; 2019 Oct; 58(10):1446-1450. PubMed ID: 31241385
[No Abstract] [Full Text] [Related]
16. Adapting radiotherapy to hypoxic tumours.
Malinen E; Søvik A; Hristov D; Bruland ØS; Olsen DR
Phys Med Biol; 2006 Oct; 51(19):4903-21. PubMed ID: 16985278
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
18. Viability of the EUD and TCP concepts as reliable dose indicators.
Ebert MA
Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
[TBL] [Abstract][Full Text] [Related]
19. A new method for optimum dose distribution determination taking tumour mobility into account.
Stavrev PV; Stavreva NA; Round WH
Phys Med Biol; 1996 Sep; 41(9):1679-89. PubMed ID: 8884905
[TBL] [Abstract][Full Text] [Related]
20. Impact of microscopic disease extension, extra-CTV tumour islets, incidental dose and dose conformity on tumour control probability.
Selvaraj J; Baker C; Nahum A
Australas Phys Eng Sci Med; 2016 Jun; 39(2):493-500. PubMed ID: 27168065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
